Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

After a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to ...

Pfizer (PFE) stock in focus as company is eyeing to sell its hospital drugs unit, Pfizer Hospital, potentially worth billions ...

Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.

Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...

Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...

Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

Havas Health has appointed Anna Maria Marra CEO of Europe. Marra is joining the healthcare agency after a 22-year run at ...

Pfizer India expanding R&D, manufacturing, and adult vaccination initiatives, showcasing commitment to the country's ...